For Korean patients, a fivefold increase in CBC risk was observed for 132 triple negative breast cancer patients with BRCA1/2 germline mutation when compared to 868 BRCA1/2 negative patients [12]. Here, BRCA1 is linked to triple-negative breast carcinoma.